These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38440737)

  • 1. Four clinical and biological phenotypes in antiphospholipid syndrome: a cluster analysis of 174 patients with antinuclear antibody tests.
    Ottavi M; Toulon P; Casolla B; Martis N
    Front Immunol; 2024; 15():1361062. PubMed ID: 38440737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying high-risk profile in primary antiphospholipid syndrome through cluster analysis: French multicentric cohort study.
    Guedon AF; Ricard L; Laurent C; De Moreuil C; Urbanski G; Deriaz S; Gerotziafas G; Elalamy I; Audemard A; Chasset F; Alamowitch S; Sellam J; Boffa JJ; Cohen A; Wahl C; Abisror N; Maillot F; Fain O; Mekinian A
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36894193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and prognostic significance of antinuclear antibodies in primary antiphospholipid syndrome: A multicenter retrospective study.
    Ricard L; Laurent C; Papo M; Deriaz S; Catano J; Alamowitch S; Kayem G; Chasset F; De Moreuil C; Boffa JJ; Gerotziafas G; Elalamy I; Bornes M; Maillot F; Audemard-Verger A; Planche V; Ballot E; Fain O; Mekinian A
    Joint Bone Spine; 2022 Mar; 89(2):105297. PubMed ID: 34656751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 cases.
    Nguyen Y; Yelnik CM; Morel N; Paule R; Stammler R; Plaçais L; Sacré K; Godeau B; Maillard H; Launay D; Morell-Dubois S; Dupré A; Lefèvre G; Devloo C; Dufrost V; Benhamou Y; Levesque H; Leroux G; Piette JC; Mouthon L; Hachulla É; Lambert M; Le Guern V; Costedoat-Chalumeau N
    Rheumatology (Oxford); 2023 Aug; 62(8):2813-2819. PubMed ID: 36190346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients.
    Sciascia S; Radin M; Cecchi I; Bertolaccini ML; Bertero MT; Rubini E; Vaccarino A; Bazzan M; Giachino O; Baldovino S; Rossi D; Mengozzi G; Roccatello D
    Rheumatology (Oxford); 2021 Mar; 60(3):1106-1113. PubMed ID: 31840749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients.
    Ma J; Song H; Wei M; He Y
    Clin Rheumatol; 2018 May; 37(5):1295-1303. PubMed ID: 28748509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and prognosis of patients with antiphospholipid antibodies based on cluster analysis: an 8-year cohort study.
    Qi W; Zhao J; Huang C; Jiang N; Li J; Wu C; Zhang S; Hu C; Xu D; Wang Q; Li M; Tian X; Zhao Y; Zeng X
    Arthritis Res Ther; 2022 Jun; 24(1):140. PubMed ID: 35690831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry.
    Zuily S; Clerc-Urmès I; Bauman C; Andrade D; Sciascia S; Pengo V; Tektonidou MG; Ugarte A; Gerosa M; Michael Belmont H; Zamorano MAA; Fortin P; Ji L; Efthymiou M; Cohen H; Branch DW; Jesus GR; Nalli C; Petri M; Rodriguez E; Cervera R; Knight JS; Atsumi T; Willis R; Bertolaccini ML; Vega J; Wahl D; Erkan D;
    Lupus; 2020 Oct; 29(11):1353-1363. PubMed ID: 32703117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE.
    Elbagir S; Grosso G; Mohammed NA; Elshafie AI; Elagib EM; Zickert A; Manivel VA; Pertsinidou E; Nur MAM; Gunnarsson I; Rönnelid J; Svenungsson E
    Lupus; 2021 Jul; 30(8):1289-1299. PubMed ID: 33957795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome.
    Kopytek M; Natorska J; Undas A
    Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome.
    Montalvão S; Elídio PS; da Silva Saraiva S; de Moraes Mazetto B; Colella MP; de Paula EV; Appenzeller S; Annichino-Bizzacchi J; Orsi FA
    Thromb Res; 2016 Dec; 148():32-37. PubMed ID: 27770664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple positive profile in antiphospholipid syndrome: prognosis, relapse and management from a retrospective multicentre study.
    Laurent C; Ricard L; Nguyen Y; Boffa JJ; Rondeau E; Gerotziafas G; Elalamy I; Deriaz S; De Moreuil C; Planche V; Johanet C; Millot F; Fain O; Mekinian A
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 37001919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstetrical outcome and treatments in seronegative primary APS: data from European retrospective study.
    Abisror N; Nguyen Y; Marozio L; Esteve Valverde E; Udry S; Pleguezuelo DE; Billoir P; Mayer-Pickel K; Urbanski G; Zigon P; De Moreuil C; Hoxha A; Bezanahary H; Carbillon L; Kayem G; Bornes M; Yelnik C; Johanet C; Nicaise-Roland P; Lambert M; Salle V; Latino OJ; Hachulla E; Benedetto C; Bourrienne MC; Benhamou Y; Alijotas-Reig J; Fain O; Mekinian A;
    RMD Open; 2020 Aug; 6(2):0. PubMed ID: 32848089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid syndrome in patients over 65 years: A comparative study of clinical and biological features and thrombotic relapses.
    Masson C; An Nguyen TT; Dufrost V; Audrain M; Hémont C; Agard C; Artifoni M; Connault J; Fouassier M; Hamidou M; Guedon AF; Wahl D; Zuily S; Espitia O
    Lupus; 2022 Dec; 31(14):1816-1823. PubMed ID: 36177950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the APS ACTION Clinical Database and Repository.
    Cecchi I; Radin M; Foddai SG; Barinotti A; Andrade D; Tektonidou MG; Pengo V; Ruiz-Irastorza G; Belmont HM; Lopez Pedrera C; Fortin PR; Gerosa M; de Jesus G; Atsumi T; Ji L; Efthymiou M; Branch DW; Nalli C; Rodriguez-Almaraz E; Petri M; Cervera R; Knight J; Artim-Esen B; Willis R; Bertolaccini ML; Cohen H; Erkan D; Sciascia S
    Rheumatology (Oxford); 2024 Oct; ():. PubMed ID: 39423147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
    Litvinova E; Darnige L; Kirilovsky A; Burnel Y; de Luna G; Dragon-Durey MA
    Front Immunol; 2018; 9():2971. PubMed ID: 30619328
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality.
    Riancho-Zarrabeitia L; Martínez-Taboada V; Rúa-Figueroa I; Alonso F; Galindo-Izquierdo M; Ovalles J; Olivé-Marqués A; Fernández-Nebro A; Calvo-Alén J; Menor-Almagro R; Tomero-Muriel E; Uriarte-Isacelaya E; Botenau A; Andres M; Freire-González M; Santos Soler G; Ruiz-Lucea E; Ibáñez-Barceló M; Castellví I; Galisteo C; Quevedo Vila V; Raya E; Narváez-García J; Expósito L; Hernández-Beriaín JA; Horcada L; Aurrecoechea E; Pego-Reigosa JM
    Lupus; 2020 Oct; 29(12):1556-1565. PubMed ID: 32807021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: Analysis of a cohort of 214 patients.
    Paule R; Morel N; Le Guern V; Fredi M; Coutte L; Belhocine M; Mouthon L; le Jeunne C; Chauvin A; Piette JC; Costedoat-Chalumeau N
    Autoimmun Rev; 2018 Sep; 17(9):866-872. PubMed ID: 30005859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.